Monthly Archives: October, 2023

Browse our exclusive articles!

KT Corp Unveils Mi:dm, Large Language Model for Next-Gen AI Services, South Korea

KT Corp. introduces Mi:dm, a large language model for corporate clients. It offers customizable service plans and advanced AI features.

Court Dismisses Artists’ Copyright Lawsuit Against AI Firms, Citing Lack of Evidence

Court dismisses artists' copyright lawsuit against AI firms, highlighting the need for substantial evidence. Learn more about the setback and its implications.

Ravin AI Receives U.S. Patent for Groundbreaking DeepDetect Solution, Revolutionizing Vehicle Inspection Accuracy and Transparency

Revolutionize car inspections with Ravin AI's patented DeepDetect solution. Enhance accuracy, transparency, and efficiency in vehicle reporting.

British PM Rishi Sunak and Elon Musk Discuss AI Risks after AI Safety Summit on X, UK

Join the conversation between British Prime Minister Rishi Sunak and Elon Musk on the risks of AI in this exciting summit. Find out more!

Biden’s Ambitious AI Executive Order Catapults US to Forefront of Regulation

Discover how Biden's new AI executive order positions the US as a frontrunner in AI regulation, surpassing Europe and other countries. Get insights on the initiatives and challenges of this order.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img